Ongoing Clinical Studies:
Title Agency PI/ Site PI
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects with Non-Radiographic Axial Spondyloarthritis AbbVie Reveille
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNF alpha Monoclonal Antibody, Administered Intravenously, in Subjects with Active Ankylosing Spondylitis Janssen Reveille
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of Certolizumab Pegol in Subjects with Active Axial Spondyloarthritis (Axial SpA) UCB Reveille
A Randomized, Open-label, Phase II/III Multicenter Study of High-dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation with Auto-CD34+HPC versus Intravenous pulse Cyclophosphamide for the Treatment of Severe Systemic Sclerosis NIH Mayes
Abatacept Systemic Sclerosis Trial NIH/BMS Mayes
A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Investigate the Efficacy and Safety of Riociguat in Patients With Diffuse Cutaneous Systemic Sclerosis Bayer Assassi